13F
中

AVTR AVANTOR INC

2026Q1 · CUSIP 05352A100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
427
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
189
Δ whales
+6
Inst. holding value
$5.3B
New positions
91
Closed positions
80
Price momentum (1Q)
-16.0%
Put / Call
7/7

Breadth history (34 quarters)

2019Q3: Δ+40 · h=149 2019Q4: Δ+14 · h=163 2020Q1: Δ+8 · h=171 2020Q2: Δ+91 · h=262 2020Q3: Δ+55 · h=317 2020Q4: Δ+67 · h=384 2021Q1: Δ+23 · h=407 2021Q2: Δ+27 · h=434 2021Q3: Δ+34 · h=468 2021Q4: Δ+25 · h=493 2022Q1: Δ-15 · h=478 2022Q2: Δ-3 · h=475 2022Q3: Δ-40 · h=435 2022Q4: Δ+9 · h=444 2023Q1: Δ+16 · h=460 2023Q2: Δ-23 · h=437 2023Q3: Δ-3 · h=434 2023Q4: Δ+34 · h=468 2024Q1: Δ+26 · h=494 2024Q2: Δ+21 · h=515 2024Q3: Δ+0 · h=515 2024Q4: Δ-23 · h=492 2025Q1: Δ-5 · h=487 2025Q2: Δ+18 · h=505 2025Q3: Δ-43 · h=462 2025Q4: Δ-46 · h=416 2026Q1: Δ+11 · h=427 2019Q3: holders=149 2019Q4: holders=163 2020Q1: holders=171 2020Q2: holders=262 2020Q3: holders=317 2020Q4: holders=384 2021Q1: holders=407 2021Q2: holders=434 2021Q3: holders=468 2021Q4: holders=493 2022Q1: holders=478 2022Q2: holders=475 2022Q3: holders=435 2022Q4: holders=444 2023Q1: holders=460 2023Q2: holders=437 2023Q3: holders=434 2023Q4: holders=468 2024Q1: holders=494 2024Q2: holders=515 2024Q3: holders=515 2024Q4: holders=492 2025Q1: holders=487 2025Q2: holders=505 2025Q3: holders=462 2025Q4: holders=416 2026Q1: holders=427 -91 -45.5 +0 +45.5 +91 134338541 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 14 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 17% -10.8% -27.4%
2024Q2 Top 12% -16.4% -30.1%
2024Q1 Top 11% +1.7% -17.0%
2023Q4 Top 16% +5.2% +6.9%
2023Q1 Top 10% +4.4% -4.9%
2021Q4 Top 19% -14.9% -23.6%
2021Q3 Top 3% -10.3% -23.7%
2021Q2 Top 9% -2.7% -9.5%

Options Sentiment

Put holders
7
QoQ: -3
Call holders
7
QoQ: -5

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.81
EPS YoY
-177.9%
Revenue (TTM)
$6.6B
Revenue YoY
-2.0%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1.9B 2022-09-30: $1.9B 2022-12-31: $1.8B 2023-03-31: $1.8B 2023-06-30: $1.7B 2023-09-30: $1.7B 2023-12-31: $1.7B 2024-03-31: $1.7B 2024-06-30: $1.7B 2024-09-30: $1.7B 2024-12-31: $1.7B 2025-03-31: $1.6B 2025-06-30: $1.7B 2025-09-30: $1.6B 2025-12-31: $1.7B 2026-03-31: $1.6B 2022-06-30: EPS 0.28 2022-09-30: EPS 0.25 2022-12-31: EPS 0.20 2023-03-31: EPS 0.18 2023-06-30: EPS -0.01 2023-09-30: EPS 0.16 2023-12-31: EPS 0.14 2024-03-31: EPS 0.09 2024-06-30: EPS 0.14 2024-09-30: EPS 0.08 2024-12-31: EPS 0.73 2025-03-31: EPS 0.09 2025-06-30: EPS 0.09 2025-09-30: EPS -1.04 2025-12-31: EPS 0.08 2026-03-31: EPS 0.06 0B 1.0B 1.9B $B -1.14 -0.17 0.80 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 36 2023-03-31: PE 22.32023-06-30: PE 33.52023-09-30: PE 36.42023-12-31: PE 50.62024-03-31: PE 65.82024-06-30: PE 47.72024-09-30: PE 46.12024-12-31: PE 17.22025-03-31: PE 12.92025-06-30: PE 13.1 12 40 69 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)